10.01.2013 Views

changing the course of stroke - New Jersey Medical School ...

changing the course of stroke - New Jersey Medical School ...

changing the course of stroke - New Jersey Medical School ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Prestigious<br />

Fellowship for<br />

Tom Denny<br />

The researcher began his career at <strong>New</strong><br />

<strong>Jersey</strong> <strong>Medical</strong> <strong>School</strong> in 1983. He’s now<br />

learning <strong>the</strong> political “ropes” in Washington<br />

and simultaneously managing a multi-million<br />

dollar federal appropriation to set up a<br />

vaccine reference lab at NJMS.<br />

HOMAS N. DENNY, MSc, assistant pr<strong>of</strong>essor <strong>of</strong> pathology,<br />

laboratory medicine and pediatrics at NJMS, was<br />

T one <strong>of</strong> seven health pr<strong>of</strong>essionals named Robert Wood<br />

Johnson Health Policy Fellows for 2002–2003 by <strong>the</strong> Institute<br />

<strong>of</strong> Medicine (IOM) <strong>of</strong> <strong>the</strong> National Academies.The fellows are<br />

all midcareer health pr<strong>of</strong>essionals working in academic and<br />

community-based settings and were chosen on a competitive<br />

basis from nominations.<br />

For three months starting in September, <strong>the</strong> researcher participated<br />

in an orientation designed to familiarize fellows with <strong>the</strong><br />

public-policy process and government health and biomedical<br />

research activities. Denny spent full days learning about current<br />

health issues, federal health and research agencies, principal congressional<br />

committees active in health affairs and major healthinterest<br />

groups.<br />

In December, <strong>the</strong> fellows moved on to part two <strong>of</strong> <strong>the</strong>ir orientation—organized<br />

by <strong>the</strong> American Political Science<br />

Association in conjunction with its Congressional Fellowship<br />

Program—to give <strong>the</strong>m a broadened perspective on <strong>the</strong> range <strong>of</strong><br />

public-policy issues and <strong>the</strong> political process. During this time,<br />

<strong>the</strong>y interviewed for <strong>the</strong>ir work assignments in <strong>the</strong> <strong>of</strong>fices <strong>of</strong> senators<br />

and representatives in Congress and <strong>the</strong> executive branch.<br />

Denny began working with <strong>the</strong> U.S. Senate Committee on<br />

Health, Education, Labor and Pensions on January 6. His first<br />

assignment was to work on a global HIV/AIDS bill, followed by<br />

biodefense, and vaccine compensation/liability legislation. As<br />

staff to <strong>the</strong> committee, he works closely with its members to get<br />

legislation passed.<br />

Denny, who is also director <strong>of</strong> <strong>the</strong> Center for Laboratory<br />

Investigation at NJMS, has studied host defense mechanisms in<br />

response to tumors and infectious diseases for 20 years. He has<br />

served on a number <strong>of</strong> committees for <strong>the</strong> NIH-NIAID Division<br />

<strong>of</strong> AIDS as part <strong>of</strong> <strong>the</strong> HIV clinical trials program. In<br />

1997, he received a NIH HIV Innovative Vaccine Grant award<br />

to study a new method <strong>of</strong> vaccine delivery. He has authored and<br />

co-authored more than 70 peer-reviewed papers.<br />

Denny has also been active in his home town, serving on <strong>the</strong><br />

Cranford Board <strong>of</strong> Education, <strong>the</strong> Cranford Township Committee<br />

and as mayor.<br />

In response to <strong>the</strong> terror attacks <strong>of</strong> 9/11, Denny established a<br />

study on UMDNJ’s <strong>New</strong>ark campus to assess immunologic<br />

memory/responses in individuals who had previously received<br />

smallpox vaccinations. He is currently analyzing interim data<br />

from <strong>the</strong> study. His next venture will be to set up a reference<br />

laboratory at NJMS to support NIH trials for smallpox vaccine<br />

and potential vaccines for anthrax and o<strong>the</strong>r agents. ●<br />

PETER BYRON NEW JERSEY MEDICAL SCHOOL 7

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!